Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Norwegian experience with nationwide implementation of fetal RHD genotyping and targeted routine antenatal anti-D prophylaxis.

Transfusion medicine (Oxford, England) - 1 Oct 2021

Sørensen Kirsten, Baevre Mette S, Tomter Geir, Llohn Abid Hussain, Hagen Kristin G, Espinosa Aurora, Jacobsen Barbora, Arsenovic Mirajana Grujic, Sørvoll Ingvild Hausberg, Ulvahaug Aud Norunn, Sundic Tatjana, Akkök Çiğdem Akalın

Abstract excerpt

OBJECTIVES: To reduce the risk of RhD alloimmunization during the last trimester of pregnancy, a targeted routine antenatal anti-D prophylaxis (RAADP) programme was implemented in Norway in 2016. Here, we present and discuss our experience with the nationwide implementation of the programme, and report sample uptake and preliminary data of de novo anti-D in pregnancy. BACKGROUND: The targeted RAADP was advised by...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Fetus
Share to Genotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Pregnancy

Share to Prenatal Diagnosis

Share to Rh-Hr Blood-Group System

Share to Rh Isoimmunization

Share to Rho(D) Immune Globulin

Source

Identifiers

PMID: 33821537
DOI: 10.1111/tme.12772

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Norwegian experience with nationwide implementation of fetal RHD genotyping and targeted routine antenatal anti-D prophylaxis.PMID 33821537Read ↗

Routine noninvasive prenatal screening for fetal <i>RHD</i> in plasma of RhD‐negative pregnant women—2 years of screening experience from DenmarkSemantic proximity Read ↗

Noninvasive fetal antigen genotyping: Results from a survey on the status of clinical implementation.Semantic proximity Read ↗

Implementation of high-throughput non-invasive prenatal testing for fetal RHD genotype testing in England: Results of a cross-sectional survey of maternity units and expert interviews.Semantic proximity Read ↗

Prenatal RHD genotyping in Croatia: preliminary results.Semantic proximity Read ↗

Noninvasive fetal RHD genotyping to guide targeted anti‐D prophylaxis–an external quality assessment workshopSemantic proximity Read ↗

Routine administration of Anti-D: the ethical case for offering pregnant women fetal RHD genotyping and a review of policy and practice.Semantic proximity Read ↗

Anti-D prophylaxis: past, present and future.Semantic proximity Read ↗

Investigation of discrepancies obtained during 15 years of non-invasive fetal RHD genotyping in apparent serologic RhD-negative pregnant women.Semantic proximity Read ↗

Non-invasive foetal RhD genotyping: A strategy for rationalizing anti-D immunoglobulin prophylaxis in RhD-negative pregnant women at the Hospital Italiano de Buenos Aires.Semantic proximity Read ↗

Routine noninvasive prenatal screening for fetal Rh D in maternal plasma-A 2-year experience from a single center in Belgium.Semantic proximity Read ↗

Prenatal screening service for fetal RHD genotyping to guide prophylaxis: the two-year experience of the Friuli Venezia Giulia region in Italy.Semantic proximity Read ↗

Screening of RHD fetal genotype in RhD negative women.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.